Research ArticleArticle
Rilonacept for Gout Flare Prevention in Patients Receiving Uric Acid-lowering Therapy: Results of RESURGE, a Phase III, International Safety Study
John S. Sundy, H. Ralph Schumacher, Alan Kivitz, Steven P. Weinstein, Richard Wu, Shirletta King-Davis and Robert R. Evans
The Journal of Rheumatology August 2014, 41 (8) 1703-1711; DOI: https://doi.org/10.3899/jrheum.131226
John S. Sundy
From the Department of Medicine, Duke University Medical Center, Durham, North Carolina; Department of Rheumatology, VA Medical Center and University of Pennsylvania, Philadelphia; Department of Rheumatology, Altoona Center for Clinical Research, Duncansville, Pennsylvania; Department of Clinical Sciences Immunology and Inflammation, Department of Biostatistics, and the Department of Clinical Operations, Regeneron Pharmaceuticals Inc., Tarrytown, New York,
USA.
H. Ralph Schumacher
Alan Kivitz
Steven P. Weinstein
Richard Wu
Shirletta King-Davis
REFERENCES
- 1.↵
- 2.↵
- 3.↵
- Garg R,
- Sayles HR,
- Yu F,
- Michaud K,
- Singh J,
- Saag KG,
- et al.
- 4.↵
- 5.↵
- Khanna P,
- Nuki G,
- Bardin T,
- Tausche AK,
- Forsythe A,
- Goren A,
- et al.
- 6.↵
- 7.↵
- 8.↵
- 9.↵
- 10.↵
- Riedel AA,
- Nelson M,
- Joseph-Ridge N,
- Wallace K,
- MacDonald P,
- Becker M
- 11.↵
- 12.↵
- 13.↵
- 14.↵
- 15.↵
- Johnson RJ,
- Segal MS,
- Srinivas T,
- Ejaz A,
- Mu W,
- Roncal C,
- et al.
- 16.↵
- 17.↵
- Katsiki N,
- Karagiannis A,
- Athyros VG,
- Mikhailidis DP
- 18.↵
- 19.↵
- 20.↵
- 21.↵
- 22.↵
- McGonagle D,
- Tan AL,
- Shankaranarayana S,
- Madden J,
- Emery P,
- McDermott MF
- 23.↵
- 24.↵
- 25.↵
- Schlesinger N,
- De Meulemeester M,
- Pikhlak A,
- Yucel AE,
- Richard D,
- Murphy V,
- et al.
- 26.↵
- Schlesinger N,
- Mysler E,
- Lin HY,
- De Meulemeester M,
- Rovensky J,
- Arulmani U,
- et al.
- 27.↵
- Schumacher HR,
- Sundy JS,
- Terkeltaub R,
- Knapp HR,
- Mellis SJ,
- Stahl N,
- et al.
- 28.↵
- Schumacher HR Jr.,
- Evans RR,
- Saag KG,
- Clower J,
- Jennings W,
- Weinstein SP,
- et al.
- 29.↵
- Mitha E,
- Schumacher HR,
- Fouche L,
- Luo S-F,
- Weinstein SP,
- Yancopoulos GD,
- et al.
- 30.↵
- 31.↵
- 32.↵Arcalyst [rilonacept] prescribing information. Regeneron Pharmaceuticals Inc., Tarrytown, NY. April 2010. [Internet. Accessed June 6, 2014.] Available from: www.regeneron.com/arcalyst
- 33.↵
- 34.↵
- 35.↵
- Schumacher HR,
- Taylor W,
- Joseph-Ridge N,
- Perez-Ruiz F,
- Chen LX,
- Schlesinger N,
- et al.
- 36.↵
- 37.↵
- 38.↵
- Choi HK,
- Curhan G
- 39.↵
In this issue
The Journal of Rheumatology
Vol. 41, Issue 8
1 Aug 2014
Rilonacept for Gout Flare Prevention in Patients Receiving Uric Acid-lowering Therapy: Results of RESURGE, a Phase III, International Safety Study
John S. Sundy, H. Ralph Schumacher, Alan Kivitz, Steven P. Weinstein, Richard Wu, Shirletta King-Davis, Robert R. Evans
The Journal of Rheumatology Aug 2014, 41 (8) 1703-1711; DOI: 10.3899/jrheum.131226
Rilonacept for Gout Flare Prevention in Patients Receiving Uric Acid-lowering Therapy: Results of RESURGE, a Phase III, International Safety Study
John S. Sundy, H. Ralph Schumacher, Alan Kivitz, Steven P. Weinstein, Richard Wu, Shirletta King-Davis, Robert R. Evans
The Journal of Rheumatology Aug 2014, 41 (8) 1703-1711; DOI: 10.3899/jrheum.131226